Mark K. Ferguson to Adult
This is a "connection" page, showing publications Mark K. Ferguson has written about Adult.
Connection Strength
0.681
-
Outpatient Thoracoscopic Mediastinal Biopsy: A Safe and Cost-Effective Approach. Ann Thorac Surg. 2020 11; 110(5):1726-1729.
Score: 0.049
-
Gender Bias Affects Assessment of Frailty and Recommendations for Surgery. Ann Thorac Surg. 2020 03; 109(3):938-944.
Score: 0.046
-
Physician Gender Differences in Processing Surgical Risk Features in Videos of Standardized Patients. Ann Thorac Surg. 2019 04; 107(4):1248-1252.
Score: 0.044
-
Do Estimates of Treatment Risk Based on Clinical Vignettes Differ by Physician Gender? Ann Thorac Surg. 2018 12; 106(6):1868-1872.
Score: 0.043
-
The Influence of Physician and Patient Gender on Risk Assessment for Lung Cancer Resection. Ann Thorac Surg. 2017 Jul; 104(1):284-289.
Score: 0.039
-
The impact of perceived frailty on surgeons' estimates of surgical risk. Ann Thorac Surg. 2014 Jul; 98(1):210-6.
Score: 0.032
-
Assessment of a scoring system for predicting complications after esophagectomy. Dis Esophagus. 2011 Sep; 24(7):510-5.
Score: 0.026
-
Modeling major lung resection outcomes using classification trees and multiple imputation techniques. Eur J Cardiothorac Surg. 2008 Nov; 34(5):1085-9.
Score: 0.021
-
Induction therapy does not increase surgical morbidity after esophagectomy for cancer. Ann Thorac Surg. 2004 Nov; 78(5):1783-9.
Score: 0.016
-
Postpneumonectomy pulmonary edema. J Cardiothorac Vasc Anesth. 2003 Jun; 17(3):388-95.
Score: 0.015
-
A comparison of three scoring systems for predicting complications after major lung resection. Eur J Cardiothorac Surg. 2003 Jan; 23(1):35-42.
Score: 0.015
-
Preoperative prediction of the risk of pulmonary complications after esophagectomy for cancer. J Thorac Cardiovasc Surg. 2002 Apr; 123(4):661-9.
Score: 0.014
-
Long-term survival after esophagectomy for Barrett's adenocarcinoma in endoscopically surveyed and nonsurveyed patients. J Gastrointest Surg. 2002 Jan-Feb; 6(1):29-35; discussion 36.
Score: 0.014
-
CDKN2A loss-of-function predicts immunotherapy resistance in non-small cell lung cancer. Sci Rep. 2021 10 08; 11(1):20059.
Score: 0.013
-
Pulmonary Parenchymal Changes in COVID-19 Survivors. Ann Thorac Surg. 2022 07; 114(1):301-310.
Score: 0.013
-
Use of fibrinolytics and deoxyribonuclease in adult patients with pleural empyema: a consensus statement. Lancet Respir Med. 2021 09; 9(9):1050-1064.
Score: 0.013
-
Clinical predictors of donor antibody titre and correlation with recipient antibody response in a COVID-19 convalescent plasma clinical trial. J Intern Med. 2021 04; 289(4):559-573.
Score: 0.012
-
Long-term outcome after resection for bronchial carcinoid tumors. Eur J Cardiothorac Surg. 2000 Aug; 18(2):156-61.
Score: 0.012
-
Does pneumonectomy for lung cancer adversely influence long-term survival? J Thorac Cardiovasc Surg. 2000 Mar; 119(3):440-8.
Score: 0.012
-
Evaluation of the Association of Perioperative UGT1A1 Genotype-Dosed gFOLFIRINOX With Margin-Negative Resection Rates and Pathologic Response Grades Among Patients With Locally Advanced Gastroesophageal Adenocarcinoma: A Phase 2 Clinical Trial. JAMA Netw Open. 2020 02 05; 3(2):e1921290.
Score: 0.012
-
Sex-associated differences in survival of patients undergoing resection for lung cancer. Ann Thorac Surg. 2000 Jan; 69(1):245-9; discussion 249-50.
Score: 0.012
-
Combined laminectomy and thoracoscopic resection of a dumbbell neurofibroma: technical case report. Neurosurgery. 1999 Nov; 45(5):1263-5; discussion 1265-6.
Score: 0.012
-
Diffusing capacity predicts operative mortality but not long-term survival after resection for lung cancer. J Thorac Cardiovasc Surg. 1999 Mar; 117(3):581-6; discussion 586-7.
Score: 0.011
-
Outcome after failed initial therapy for rupture of the esophagus or intrathoracic stomach. J Gastrointest Surg. 1997 Jan-Feb; 1(1):34-9.
Score: 0.010
-
Use of pleural catheter for the management of simple pneumothorax. Chest. 1996 Nov; 110(5):1169-72.
Score: 0.009
-
Results of myotomy and partial fundoplication after pneumatic dilation for achalasia. Ann Thorac Surg. 1996 Aug; 62(2):327-30.
Score: 0.009
-
Limitations of PET/CT in the Detection of Occult N1 Metastasis in Clinical Stage I(T1-2aN0) Non-Small Cell Lung Cancer for Staging Prior to Stereotactic Body Radiotherapy. Technol Cancer Res Treat. 2017 02; 16(1):15-21.
Score: 0.009
-
Doubling of 30-Day Mortality by 90 Days After Esophagectomy: A Critical Measure of Outcomes for Quality Improvement. Ann Surg. 2016 Feb; 263(2):286-91.
Score: 0.009
-
Retroperitoneal placement of an ICD generator: a solution for a difficult problem. Pacing Clin Electrophysiol. 1996 Jan; 19(1):130-1.
Score: 0.009
-
Current results of therapy for esophageal perforation. Am J Surg. 1995 Jun; 169(6):615-7.
Score: 0.009
-
Intensive multimodality therapy for carcinoma of the esophagus and gastroesophageal junction. Ann Surg Oncol. 1995 Mar; 2(2):101-6.
Score: 0.008
-
External validation of the Ferguson pulmonary risk score for predicting major pulmonary complications after oesophagectomy†. Eur J Cardiothorac Surg. 2016 Jan; 49(1):333-8.
Score: 0.008
-
How accurate are anatomic landmarks for femoral tunnel positioning in anterior cruciate ligament reconstruction? An in vivo imaging analysis comparing both anteromedial portal and outside-in techniques. Arthroscopy. 2015 May; 31(5):882-9.
Score: 0.008
-
Transcervical thymectomy for myasthenia gravis. Ann Thorac Surg. 1994 Jan; 57(1):194-7.
Score: 0.008
-
Improved survival associated with neoadjuvant chemoradiation in patients with clinical stage IIIA(N2) non-small-cell lung cancer. J Thorac Oncol. 2013 Jul; 8(7):915-22.
Score: 0.008
-
Pathologic response rates following definitive dose image-guided chemoradiotherapy and resection for locally advanced non-small cell lung cancer. Lung Cancer. 2011 Dec; 74(3):446-50.
Score: 0.007
-
MET and phosphorylated MET as potential biomarkers in lung cancer. J Environ Pathol Toxicol Oncol. 2011; 30(4):341-54.
Score: 0.006
-
Predicting failure following shunting of pleural effusions. Chest. 1990 Oct; 98(4):890-3.
Score: 0.006
-
Long-term outcome of a phase II study of docetaxel-based multimodality chemoradiotherapy for locally advanced carcinoma of the esophagus or gastroesophageal junction. Med Oncol. 2011 Dec; 28 Suppl 1:S152-61.
Score: 0.006
-
Sex-associated differences in presentation and survival in patients with lung cancer. J Clin Oncol. 1990 Aug; 8(8):1402-7.
Score: 0.006
-
Early evaluation and therapy for caustic esophageal injury. Am J Surg. 1989 Jan; 157(1):116-20.
Score: 0.005
-
Lymphatic vessel density is not associated with lymph node metastasis in non-small cell lung carcinoma. Arch Pathol Lab Med. 2008 Dec; 132(12):1882-8.
Score: 0.005
-
Diffusing capacity predicts morbidity and mortality after pulmonary resection. J Thorac Cardiovasc Surg. 1988 Dec; 96(6):894-900.
Score: 0.005
-
Phase I study of induction chemotherapy and concomitant chemoradiotherapy with irinotecan, carboplatin, and paclitaxel for stage III non-small cell lung cancer. J Thorac Oncol. 2008 Jan; 3(1):59-67.
Score: 0.005
-
Selective operative approach for diagnosis and treatment of anterior mediastinal masses. Ann Thorac Surg. 1987 Dec; 44(6):583-6.
Score: 0.005
-
Phase I study of vinorelbine, cisplatin, and concomitant thoracic radiation in the treatment of advanced chest malignancies. J Clin Oncol. 1998 Jun; 16(6):2157-63.
Score: 0.003
-
Induction chemotherapy, surgery, and concomitant chemoradiotherapy for carcinoma of the esophagus: a long-term analysis. Ann Oncol. 1998 Jun; 9(6):647-51.
Score: 0.003
-
Management of giant paraesophageal hernia. Dis Esophagus. 1997 Jan; 10(1):47-50.
Score: 0.002
-
Vinorelbine (Navelbine), cisplatin, and concomitant radiation therapy for advanced malignancies of the chest: a Phase I study. Semin Oncol. 1996 Apr; 23(2 Suppl 5):48-52.
Score: 0.002
-
A phase I trial of concomitant chemoradiotherapy with cisplatin dose intensification and granulocyte-colony stimulating factor support for advanced malignancies of the chest. Cancer Chemother Pharmacol. 1995; 35(4):304-12.
Score: 0.002
-
Dedifferentiated chordoma. Response to aggressive chemotherapy in two cases. Cancer. 1993 Aug 01; 72(3):714-8.
Score: 0.002
-
The impact on survival by adjuvant chemotherapy and radiation therapy in stage II non-small-cell lung cancer. Am J Clin Oncol. 1992 Oct; 15(5):405-11.
Score: 0.002
-
Pericardial window: mechanisms of efficacy. Ann Thorac Surg. 1990 Sep; 50(3):442-5.
Score: 0.002
-
5-Fluorouracil with oral leucovorin and hydroxyurea and concomitant radiotherapy for stage III non-small cell lung cancer. Cancer. 1990 Aug 01; 66(3):437-42.
Score: 0.002
-
Efficacy of computed tomography of the thorax and upper abdomen and whole-body gallium scintigraphy for staging of lung cancer. Cancer. 1989 Oct 01; 64(7):1404-8.
Score: 0.001
-
Treatment of carcinoma of the proximal esophagus. Surg Gynecol Obstet. 1989 Apr; 168(4):307-10.
Score: 0.001
-
Pleuro-peritoneal shunting. Alternative therapy for pleural effusions. Ann Surg. 1988 Oct; 208(4):443-50.
Score: 0.001
-
Colon interposition for benign esophageal disease. Surgery. 1987 Oct; 102(4):568-74.
Score: 0.001